KONSTANTIN TSOYI to Macular Degeneration
This is a "connection" page, showing publications KONSTANTIN TSOYI has written about Macular Degeneration.
Connection Strength
0.211
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.
Score: 0.211
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.